Vanda Pharmaceuticals Inc.
VNDA
$5.25
-$0.08-1.50%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -310.61% | -441.37% | -1,066.53% | -413.78% | -512.58% |
| Total Depreciation and Amortization | 33.77% | 37.77% | 39.13% | 55.94% | 90.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 869.46% | 1,442.50% | 91,009.18% | -263.16% | -1,042.69% |
| Change in Net Operating Assets | 171.93% | 115.13% | 226.68% | 234.65% | 381.37% |
| Cash from Operations | -119.66% | -124.02% | -594.56% | -363.12% | -1,160.40% |
| Capital Expenditure | 39.28% | 67.95% | 78.85% | 98.95% | 98.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 164.12% | 52.71% | 854.13% | 37.00% | -27.72% |
| Cash from Investing | 169.17% | 59.30% | 644.23% | 182.79% | 206.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -182.00% | -318.09% | -1,184.52% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -46.48% | -59.43% | -1,774.84% | -- | -- |
| Foreign Exchange rate Adjustments | -616.33% | 17.00% | 114.11% | -205.29% | 5,000.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.25% | -332.29% | 47.87% | 63.15% | 53.33% |